The objective of Dorphan is the preclinical and clinical development of innovative therapeutic solutions for orphan and rare genetic diseases affecting mainly children, with a strong focus on two related lysosomal storage diseases, GM1-gangliosidosis and Morquio disease type B.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2011
  • Number of employees in Switzerland
    1-9
Key business